Status:

COMPLETED

Shared Meditation Involving People With Cancer, Carers and Third Parties

Lead Sponsor:

Centre Francois Baclesse

Conditions:

Patients With Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Although the benefits of meditation are increasingly well documented, few hospitals offer this integrative approach in their supportive cancer care. Meditation is sometimes provided, but its potential...

Detailed Description

The main aims of this randomised study are to improve well-being, strengthen links between carers, patients and third parties and raise awareness of the importance of living together better by offerin...

Eligibility Criteria

Inclusion

  • Criteria for all participants (patients, carers and third parties)
  • Participant with no current or previous experience of regular or intensive meditation or comparable practice. Practice is considered regular and/or intensive if :
  • it occurs more than one day a week for more than 6 consecutive months over the last 10 years,
  • and/or more than 5 consecutive days of intensive practice (course or retreat) in the last 10 years,
  • and/or more than 25 consecutive days of retreat (cumulative) in the last 10 years.
  • Patient-specific criteria (target population) - Cancer patients (regardless of location)
  • Specific criteria for carers
  • \- All medical and/or paramedical care staff at the Centre François Baclesse in contact with patients (doctors, nurses, nursing assistants, radiotherapy technicians, etc.)
  • Specific criteria for third parties- Any volunteer not belonging to the two categories above

Exclusion

  • Participants with significant vulnerability factors such as alcohol or drug dependence, severe depression, severe social anxiety, recent bereavement, etc.)
  • Participant unable to undergo trial monitoring for geographical, social or psychopathological reasons

Key Trial Info

Start Date :

January 9 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 26 2024

Estimated Enrollment :

96 Patients enrolled

Trial Details

Trial ID

NCT06041607

Start Date

January 9 2024

End Date

June 26 2024

Last Update

July 11 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centre François Baclesse

Caen, France